BIO International Convention Will Feature Expanded Innovation Zone

May 25, 2015

The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) have agreed to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in an expanded Innovation Zone at the 2015 BIO International Convention®, on tap in June in Philadelphia.

The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO One-on-One Partnering™.

“We are thrilled to announce our expanded partnership with the National Institutes of Health and the National Science Foundation to bring the Innovation Zone to Philadelphia this year,” said Scott Whitaker, president of the BIO International Convention.  

He added, “Each of these companies, through their selection as SBIR grantees, have demonstrated transformational technology with large potential societal and market impact, presenting a unique opportunity for investors. Based upon the popularity of the inaugural Innovation Zone last year, we are planning to nearly double the size for 2015.”

Select companies will make 15-minute company presentations in the BIO Business Forum. The Innovation Zone will also feature six universities funded under the prestigious NSF Accelerating Innovation Research Program (AIR). This select group will demonstrate advanced biomedical prototypes that are very close to commercialization stage.

“NIH is committed to supporting exceptional innovation through the SBIR program. The early-stage companies showcased in this year's Innovation Zone highlight some of the most promising technologies and significant non-dilutive investments that we hope will achieve commercial success and significantly advance human health,” said Dr. Lenka Fedorkova, NIH SBIR/STTR program manager.

She added, “In order to move toward this goal, however, these companies require critical partnerships and capital. I encourage attendees to meet with our companies and explore the featured exhibits and presentations.”

Each of the companies has been rigorously vetted through the SBIR/STTR review process prior to receiving the non-dilutive funding to engage in R&D that has the potential for commercialization. The NIH and NSF invest a combined $940 million annually in the programs.

“The technology behind some of today’s greatest innovations have come from inventive small companies,” said Jesus Soriano, a program director for NSF's SBIR/STTR program.  

He added, “World-class tradeshows like the BIO Convention offer federally supported tech pioneers -- who have big ideas, but limited resources -- the opportunity to showcase their emerging research. This year, dozens of NSF-funded companies and several academic laboratories with prototypes will be available to talk about their high-risk, high-reward projects, which will span a wide range of topics from new therapeutic platforms to detection methods.”

Add new comment

Partner Voices
MGM Resorts is committed to fostering an inclusive and diverse culture, not just among employees and guests but also within its supply chain. The company prioritizes procuring goods and services from businesses owned by minorities, women, veterans, people with disabilities, LGBTQ individuals and those facing economic disadvantages. This commitment is integral to MGM Resorts' global procurement strategy.    Through its voluntary supplier diversity program, MGM Resorts actively identifies and connects certified diverse-owned suppliers to opportunities within its supply chain. The company is on track to spend at least 15% of its biddable procurement with diverse-owned businesses by 2025, demonstrating that supplier diversity is not only a social responsibility but also a strategic business imperative.    Supplier diversity isn’t just the right thing to do – it’s good for business. A diverse supply chain allows access to a broader range of perspectives and experience, helping to drive innovation, entrepreneurship and resilience, while strengthening communities. At MGM Resorts, engaging diverse suppliers ensures best-in-class experiences for guests and clients. Supplier diversity ensures a more resilient supply chain while supporting economic development in the communities in which it operates.   The impact of MGM Resorts' supplier diversity initiatives is significant. In 2023, these efforts supported over 3,500 jobs across more than 30 states, contributed over $214 million in income for diverse-owned businesses and generated more than $62 million in tax revenue. The story extends beyond the numbers – it reflects the tangible benefits brought to small and diverse-owned businesses, fostering economic empowerment in their communities.    MGM Resorts also supports the development and business skills of diverse-owned businesses through investment, mentorship and education. Through the MGM Resorts Supplier Diversity Mentorship Program, the company identifies, mentors and develops diverse-owned businesses to fill its future pipeline, while providing businesses with tools and resources to empower and uplift. Since 2017, the program has successfully graduated 105 diverse-owned businesses and is on track to achieve its goal of 150 graduates by 2025.     MGM Resorts’ commitment to supplier diversity not only enhances its business operations but also plays a crucial role in uplifting communities and fostering economic development. This approach reinforces the idea that diversity is a powerful driver of innovation and resilience, benefiting both the company and the wider community.